The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of Phase 2 and Phase 3 Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S31, 2018. DOI: 10.25251/skin.2.supp.30. Disponível em: https://skin.dermsquared.com/skin/article/view/272. Acesso em: 24 may. 2026.